TY - JOUR
T1 - Modeling the interaction of SARS-CoV-2 binding to the ACE2 receptorviamolecular theory of solvation
AU - Kobryn, Alexander E.
AU - Maruyama, Yutaka
AU - Velázquez-Martínez, Carlos A.
AU - Yoshida, Norio
AU - Gusarov, Sergey
N1 - Funding Information:
We thank Mr Renato Caldart, Senior Advisor, International Relations, National Research Council Canada (NRC), for his advice and kind support for this study. We also acknowledge the support from the broader NRC and RIKEN collaboration promotion teams in organizing the High-Performance Computing Workshop that inspired new ideas and created new connections for the authors. G. S. acknowledges the BIOVIA Inc. for providing a six-month license to “Discovery Studio” 44 for SARS-CoV-2 related studies.
Publisher Copyright:
© The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2021.
PY - 2021/9/14
Y1 - 2021/9/14
N2 - The angiotensin-converting enzyme 2 (ACE2) protein is a cell gate receptor for the SARS-CoV-2 virus, responsible for the development of symptoms associated with the Covid-19 disease. Pharmacological inhibition of the SARS-CoV-2 spike receptor binding domain (RBD) and ACE2 interaction is one of the most attractive ways to prevent viral replication in human cells. Unfortunately, at this stage there is no complete picture of this process and so the computational modelling might provide an important insight valuable for the development of new and efficient inhibitors. In this work we propose the use of the molecular theory of solvation to study the nanomorphology of the spike-ACE2 binding formed by a complex solvent (water, ions, and dissolved drug-like molecules) and leading to the viral protein with cell membrane receptors. In contrast to the typical molecular dynamics, the statistical-mechanical theory of solvation directly provides distributions of complex solvents around the binding location as well as the thermodynamics of solvation. We present an example of the application of the three-dimensional theory of solvation to model the nanomorphology formed by solvent environment around binding surfaces of interacting proteins. The results of our calculations are compared with the other published data. Our recent developments allow the application of the methodology to be extended to potential drug screening and virulence analysis.
AB - The angiotensin-converting enzyme 2 (ACE2) protein is a cell gate receptor for the SARS-CoV-2 virus, responsible for the development of symptoms associated with the Covid-19 disease. Pharmacological inhibition of the SARS-CoV-2 spike receptor binding domain (RBD) and ACE2 interaction is one of the most attractive ways to prevent viral replication in human cells. Unfortunately, at this stage there is no complete picture of this process and so the computational modelling might provide an important insight valuable for the development of new and efficient inhibitors. In this work we propose the use of the molecular theory of solvation to study the nanomorphology of the spike-ACE2 binding formed by a complex solvent (water, ions, and dissolved drug-like molecules) and leading to the viral protein with cell membrane receptors. In contrast to the typical molecular dynamics, the statistical-mechanical theory of solvation directly provides distributions of complex solvents around the binding location as well as the thermodynamics of solvation. We present an example of the application of the three-dimensional theory of solvation to model the nanomorphology formed by solvent environment around binding surfaces of interacting proteins. The results of our calculations are compared with the other published data. Our recent developments allow the application of the methodology to be extended to potential drug screening and virulence analysis.
UR - http://www.scopus.com/inward/record.url?scp=85114122215&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114122215&partnerID=8YFLogxK
U2 - 10.1039/d1nj02015c
DO - 10.1039/d1nj02015c
M3 - Article
AN - SCOPUS:85114122215
VL - 45
SP - 15448
EP - 15457
JO - New Journal of Chemistry
JF - New Journal of Chemistry
SN - 1144-0546
IS - 34
ER -